Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06253637
Title Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program (DARATALL-VHR)
Acronym DARATALL-VHR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.